Medicine Overview of Olmin AH Tablet
Nausea, Altered taste, Diarrhoea, Stomach upset, Headache, Dizziness, Decreased blood pressure, Flushing of skin, Increased blood uric acid, Numbness of extremity, Increased blood lipid level, Decreased sodium level in blood, Decreased magnesium level in blood.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Olmin AH 20 mg/5 mg/12.5 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Olmin AH 20 mg/5 mg/12.5 mg Tablet is a combination of three medicines: Olmesartan, Amlodipine and Hydrochlorothiazide. Olmesartan is an angiotensin receptor blocker (ARB) and Amlodipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Hydrochlorothiazide is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
In Depth Information on Olmin AH Tablet
Olmin AH Tablet related warnings
Taking Hydrochlorothiazide with alcohol may have additive effects in lowering blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Olmin AH 20 mg/5 mg/12.5 mg Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Olmin AH 20 mg/5 mg/12.5 mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
Olmin AH 20 mg/5 mg/12.5 mg Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Olmin AH 20 mg/5 mg/12.5 mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olmin AH 20 mg/5 mg/12.5 mg Tablet may be needed. Please consult your doctor.
Use of Olmin AH 20 mg/5 mg/12.5 mg Tablet is not recommended in patients with severe kidney disease.
Olmin AH 20 mg/5 mg/12.5 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Olmin AH 20 mg/5 mg/12.5 mg Tablet may be needed. Please consult your doctor.
One of the following vendor pharmacies will deliver Olmin AH 20 mg/5 mg/12.5 mg Tablet: QTM, EMB, NSL, SHD, HSP, OLT, AMR, SVH, HGI, BBS, DYG, MAM, BHM, HPC, NNH, ZVP, GTC, ESY, BLE, CLT, SPD, RPP, KHC, NDP, BTM, EVP, PTI, MDH, AGT, MMS, 9T9, AAR, SCH, RHW, AYU, TRP, BAL, SWP, WSI, FGH, KHH, HTS, PWN, SWA, AAY, DPP, JVO, RHL, BSN, MPC, TOM, PPR, OIP, JIV, HAT, SSA, DAO, SHC, ARD, RKS, GHR, RUS, RPI, SRG, PNT, SBA, HBV, LCC, STA, THP, NAS, MSD, RDR, GTK, BHP, GPT, ADT, BAP, JSL, UMP, DLP, RSA, DFP, PMA, IAD, HEX, INC, HIP, NTB, KMC, VRS, VNS, PVP, JVN, TFP, NXG, QLF, MLC, WHL, RSS, RDH, SGH, OHM, SJP, GNC, DVH, SBL, PLT, OWP, BIO, RJH, USF, ENP, TNH, BMJ, PEN, NVL, GPP, SGC, DGN, MAK, BDN, EQN, SYN, MAX, AYM, ATP, DPL, SHP, ATL, SVS, LHA, RWP, MDO, SDM, HZF, HNP, PRN, ZEL, VDH, SAF, NVY, HMP, DHR, IPL, P2P, ANT, GBL, ABP, SLN